Healthcare Industry Developments | BioTuesdays by Kilmer Lucas IR

Developments

Defence opens first U.S. laboratory

Defence Therapeutics (CSE: DTC; OTCQB: DTCFF; FSE: DTC) announced that it has opened its first U.S.-based laboratory in the Boston-Cambridge area. According to Defence, the new laboratory will allow the company to...

June 2, 2025

Developments

atai and Beckley to combine establishing market leader in psychedelic mental health therapies

atai Life Sciences (NASDAQ: ATAI) and closely held Beckley Psytech announced a definitive agreement to combine in an all-share transaction subject to Phase 2b success criteria of BPl-003 in patients with treatment...

June 2, 2025

Developments

Genflow and CER agree to long-term R&D collaboration

Genflow Biosciences (LSE:GENF; OTCQB:GENFF) has announced the signing of a master service agreement (MSA) with closely held CER Groupe—a long-standing partner—to strengthen long-term research and development (R&D)...

May 28, 2025

Developments

NeoGenomics introduces PanTracer genomic profiling tests at ASCO 2025

NeoGenomics (NASDAQ: NEO) has announced that it will debut its PanTracer Family genomic profiling tests for advanced solid tumors at the 2025 American Society of Clinical Oncology (ASCO) in Chicago May 30—June 3, 2025...

May 28, 2025

Developments

Perimeter partners with Intermountain Health to study benefits of using OCT and AI to reduce cancer reoperations

Perimeter Medical Imaging AI (TSXV: PINK; OTCQX: PYNKF) has announced that it has entered into a development support agreement with Intermountain Health, creating the framework for the two organizations to partner on a...

May 23, 2025

Developments

FDA clears Quoin’s second QRX003 NS pivotal study

Quoin Pharmaceuticals (NASDAQ: QNRX) announced that the FDA has provided clearance to initiate a second Netherton Syndrome (NS) clinical pivotal study—CL-QRX003-002, for Quoin’s lead product QRX003. According to Quoin...

May 22, 2025

Developments

NorthStrive completes Phase 1 review for oral myostatin-engineered probiotic

NorthStrive Biosciences (NASDAQ:ELAB) announced the completion of a Phase I strategic research and literature synthesis for EL-22 (formerly BLS-M22), its first-in-class oral myostatin-engineered probiotic targeting...

May 22, 2025

Developments

Zura Bio launches global Phase 2 study of tibulizumab in HS

Zura Bio (NASDAQ:ZURA) announced that it has launched a global Phase 2 study—TibuSHIELD—to evaluate tibulizumab in 180 adults with moderate to severe hidradenitis suppurativa (HS) across Canada, the U.S. and Europe...

May 21, 2025

Developments

Neurogene announces treatment intended to reverse HLH associated with high-dose AAV

Neurogene (NASDAQ:NGNE) has announced an oral presentation at the American Society of Gene and Cell Therapy (ASGCT) annual meeting this week describing a monitoring and treatment algorithm intended to reverse the rare...

May 16, 2025

Developments

CAMP4 presents translational data from SYNGAP1-related disorders program at ASGCT annual meeting

CAMP4 Therapeutics (NASDAQ:CAMP) has announced that three oral presentations on its SYNGAP1-related disorders and Urea Cycle Disorders (UCDs) programs, and shared favorable safety and pharmacokinetics data from the...

May 16, 2025

Developments

Ekso Bionics accepted into NVIDIA Connect program

Ekso Bionics Holdings (NASDAQ:EKSO) has announced its acceptance into the NVIDIA Connect program, enabling access to valuable tools and resources to support a new strategic initiative to build a proprietary foundation...

May 15, 2025

Developments

Social Capital’s Chamath Palihapitiya highlights latest developments on Perimeter Medical’s Next-gen, AI-driven B-Series OCT device on X

In a May 13, 2025 post on X, Chamath Palihapitiya, renowned Silicon Valley venture capitalist, entrepreneur, and former Facebook executive, provided the latest updates on Perimeter Medical Imaging AI (TSXV:PINK;...

May 14, 2025

Developments

Radiology Today spotlights Perimeter’s next-gen, AI-enabled B-Series OCT for interoperative cancer margin assessment during breast-conserving surgeries

The May issue of Radiology Today magazine features an interview with Andrew Berkeley, co-founder and chief innovation officer of Perimeter Medical Imaging AI (TSXV:PINK; OTCQX:PYNKF), and highlights both the...

May 13, 2025

Developments

Zynex submits FDA application for NiCO device

Zynex (NASDAQ:ZYXI) announced it has submitted a 510(k) application to the FDA for its NiCO Noninvasive CO-Oximeter device. The company stated that the submission marks a historic milestone in the evolution of pulse...

May 12, 2025

Developments

IPA reports new results validating in silico epitope mapping application

ImmunoPrecise Antibodies (IPA) (NASDAQ:IPA) announced new benchmarking results validating the accuracy and utility of its in silico epitope mapping application—part of the LENSai platform, which delivers x-ray-level...

May 12, 2025

Developments

FDA accepts Omeros’ BLA resubmission for narsoplimab in TA-TMA

Omeros Corporation (NASDAQ:OMER) announced that the FDA will review its resubmission of the Biologics License Application (BLA) for narsoplimab for the treatment of hematopoietic stem cell transplant-associated...

May 6, 2025

Developments

WHO approves Moleculin’s name for next-gen anthracycline

Moleculin Biotech (NASDAQ:MBRX) announced that the International Nonproprietary Names (INN) expert committee of the World Health Organization (WHO) has approved “naxtarubicin” as the non-proprietary name of its next...

May 6, 2025

Developments

Firefly acquires Evoke Neuroscience—resulting in multi-fold database, IP portfolio, and commercial footprint expansion

Firefly Neuroscience (NASDAQ:AIFF) has announced its acquisition of closely held Evoke Neuroscience, a medical device company developing and commercializing technologies to aid in the comprehensive assessment of brain...

May 5, 2025

Developments

Positive results from Perimeter’s B-Series OCT with ImgAssist AI 2.0 pivotal trial presented at ASBrS 2025

Perimeter Medical Imaging AI (TSXV:PINK; OTCQX:PYNKF) announced that detailed, positive results from the pivotal trial evaluating the use of its next-generation B-Series OCT with ImgAssist AI 2.0 for intraoperative...

May 5, 2025

Developments

electroCore acquires NeuroMetrix gaining access to Quell platform

electroCore (NASDAQ:ECOR) announced it has completed the merger with NeuroMetrix (NASDAQ:NURO), expanding its portfolio to include Quell Fibromyalgia Solution, strengthening its commercial reach, and positioning the...

May 2, 2025

Developments

Vaccine publishes study demonstrating benefits of PharmaJet’s Tropis needle-free system

Closely held PharmaJet announced the publication of a study in the top-tier journal Vaccine, which demonstrates the benefits of the company’s Tropis needle-free system compared to needle and syringe (N/S) for...

May 1, 2025

Developments

Profound reports positive perioperative data from randomized CAPTAIN trial comparing TULSA with Robotic Prostatectomy; Lake Street analyst suggests trial data will be well received by payors

Profound Medical (NASDAQ:PROF; TSX:PRN) announced initial perioperative data from its Level 1 post-market CAPTAIN trial comparing the safety and efficacy of the TULSA procedure with radical prostatectomy (RP) in men...

April 30, 2025

Subscribe